CHEMOTHERAPY IN HEAD AND NECK-CANCER .1. MANAGEMENT OF RECURRENT OR METASTATIC DISEASE

被引：0
作者：
GEBBIA, V
ZERILLO, G
GEBBIA, N
AGOSTARA, B
CALLARI, A
RAUSA, L
机构：
来源：
JOURNAL OF CHEMOTHERAPY | 1992年 / 4卷 / 04期
关键词：
HEAD NECK CANCER; SYSTEMIC CHEMOTHERAPY; METASTATIC DISEASE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
This paper is an up-dated review of the role of systemic chemotherapy in the management of recurrent and/or metastatic head and neck carcinoma.
引用
收藏
页码：244 / 259
页数：16
相关论文
共 50 条
  • [31] Lack of efficacy of topotecan in the treatment of metastatic or recurrent squamous carcinoma of the head and neck - An Eastern Cooperative Oncology Group trial (E3393)
    Murphy, BA
    Leong, T
    Burkey, B
    Langer, C
    Forastiere, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (01): : 64 - 66
  • [32] The role of image-guided therapy in the management of colorectal cancer metastatic disease
    de Baere, Thierry
    Tselikas, Lambros
    Yevich, Steven
    Boige, Valerie
    Deschamps, Frederic
    Ducreux, Michel
    Goere, Diane
    Nguyen, France
    Malka, David
    EUROPEAN JOURNAL OF CANCER, 2017, 75 : 231 - 242
  • [33] Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
    Koukourakis, Ioannis M.
    Giakzidis, Axiotis G.
    Koukourakis, Michael I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (10) : 3032 - 3041
  • [34] Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
    Ioannis M. Koukourakis
    Axiotis G. Giakzidis
    Michael I. Koukourakis
    Clinical and Translational Oncology, 2023, 25 : 3032 - 3041
  • [35] Value of Fluoro-2-Deoxy-D-Glucose-Positron Emission Tomography for Detecting Metastatic Lesions in Head and Neck Cancer
    Fogh, Shannon E.
    Kubicek, Gregory J.
    Champ, Colin
    Intenzo, Charles
    Axelrod, Rita
    Keane, William M.
    Machtay, Mitchell M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (04): : 311 - 315
  • [36] Communicative Participation From the Perspective of People Suffering From a Palliative Head-Neck-Cancer Disease
    Petry, Jennifer
    Marotzki, Ulrike
    Barthel, Maria
    ZEITSCHRIFT FUR PALLIATIVMEDIZIN, 2025, 26 (01): : 45 - 54
  • [37] Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy Little Evidence of Improvement Over the Past 30 Years
    Tevaarwerk, Amye J.
    Gray, Robert J.
    Schneider, Bryan P.
    Smith, Mary Lou
    Wagner, Lynne I.
    Fetting, John H.
    Davidson, Nancy
    Goldstein, Lori J.
    Miller, Kathy D.
    Sparano, Joseph A.
    CANCER, 2013, 119 (06) : 1140 - 1148
  • [38] Management of Oral Hygiene in Head-Neck Cancer Patients Undergoing Oncological Surgery and Radiotherapy: A Systematic Review
    Lanzetti, Jacopo
    Finotti, Federica
    Savarino, Maria
    Gassino, Gianfranco
    Dell'Acqua, Alessandro
    Erovigni, Francesco M.
    DENTISTRY JOURNAL, 2023, 11 (03)
  • [39] Systemic Chemotherapy with Cisplatin Plus 5-FU (PF) for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): Efficacy and Safety of a Lower Dose of PF (80/800) at a Single Institution in Japan
    Kiyota, Naomi
    Tahara, Makoto
    Kadowaki, Shigenori
    Fuse, Nozomu
    Doi, Toshihiko
    Minami, Hironobu
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (04) : 225 - 230
  • [40] Predictive value of skin invasion in recurrent head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using a cyberknife
    Yamazaki, Hideya
    Ogita, Mikio
    Himei, Kengo
    Nakamura, Satoaki
    Suzuki, Gen
    Kotsuma, Tadayuki
    Yoshida, Ken
    Yoshioka, Yasuo
    RADIATION ONCOLOGY, 2015, 10
12345